DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 164 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,528 | +34.0% | 160,690 | +37.4% | 0.02% | +58.3% |
| Q4 2023 | $1,886 | -55.9% | 116,932 | -65.2% | 0.01% | -70.7% |
| Q3 2023 | $4,272 | -43.8% | 335,885 | -37.8% | 0.04% | -33.9% |
| Q2 2023 | $7,608 | +13.3% | 540,316 | +24.3% | 0.06% | +10.7% |
| Q1 2023 | $6,716 | -29.3% | 434,670 | -25.0% | 0.06% | -59.4% |
| Q4 2022 | $9,501 | -99.8% | 579,654 | +87.6% | 0.14% | +84.0% |
| Q3 2022 | $5,716,000 | +20.7% | 308,969 | -14.2% | 0.08% | +29.3% |
| Q2 2022 | $4,734,000 | +84.3% | 360,015 | +29.9% | 0.06% | +81.2% |
| Q1 2022 | $2,569,000 | +230.6% | 277,155 | +1936.7% | 0.03% | +300.0% |
| Q4 2020 | $777,000 | – | 13,608 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $19,824,869 | 14.35% |
| Redmile Group, LLC | 3,593,317 | $58,894,466 | 2.41% |
| BRAIDWELL LP | 3,271,513 | $53,620,098 | 1.80% |
| Parkman Healthcare Partners LLC | 344,920 | $5,653,239 | 1.50% |
| ARMISTICE CAPITAL, LLC | 5,172,000 | $84,769,080 | 1.48% |
| Ikarian Capital, LLC | 367,119 | $6,017,081 | 1.45% |
| Sunesis Advisors, LLC | 96,299 | $1,578,341 | 1.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,349,228 | $38,503,847 | 0.80% |
| Hillsdale Investment Management Inc. | 328,200 | $5,379,198 | 0.46% |
| Avidity Partners Management LP | 1,126,000 | $18,455,140 | 0.40% |